US Patent 7745157 Human lymphocyte medium adjuvant
All edits
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+378 characters)
Article
Patent abstract
The present invention relates to an adjuvant derived from human lymphocytes. The adjuvant can be used in combination with traditional vaccines or cancer immunotherapy, to enhance the response of the patient's immune system to the vaccine or other immunotherapeutic agent. The adjuvant is derived from the supernatant collected from cultured activated lymphocytes.
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Dean LeMar Mann0
Kenichiro Hasumi0
Kim Graulich Hankey0
Kristina Michelle Holt0
Edits on 21 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 16 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07745157 Human lymphocyte medium adjuvant US Patent 7745157 Human lymphocyte medium adjuvant
Infobox
Patent Number
07745157
Patent Number
7745157
Edits on 3 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 4 Dec, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07745157 Human lymphocyte medium adjuvant
Infobox
Is a
Patent jurisdiction
Patent number
07745157
Date of patent
June 29, 2010
Patent application number
10783259
Date Filed
February 20, 2004
Patent primary examiner
Find more entities like US Patent 7745157 Human lymphocyte medium adjuvant
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
